Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: An observational, retrospective case series study

American Journal of Clinical Dermatology

Volumn 13, Issue 1, 2012, Pages 49-54

  Mittmann, Nicole ^a   Knowles, Sandra R ^b   Koo, Marika ^a   Shear, Neil H ^b   Rachlis, Anita ^b   Rourke, Sean B ^c  

^a Sunnybrook Health Sciences Centre   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

HIV infections; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; RIFABUTIN; STAVUDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZIDOVUDINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADULT; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ONTARIO; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME;

EID: 84055193725     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11593240-000000000-00000     Document Type: Article

References (30)

1. Fritsch PO, Ruiz-Maldonado R. Stevens-Johnson syndrome-toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick's dermatology in general medicine. 5th ed. Toronto (ON): McGraw-Hill, 1999: 644-50
2. Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129 (1): 92-6 (Pubitemid 23029676)
3. Roujeau JC, Chosidow O, Saiag P, et al. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23 (6 Pt 1): 1039-58
4. Schopf E, Stuhmer A, Rzany B, et al. Toxic epidermal necrolysis and Stevens- Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127 (6): 839-42
5. Naldi L, Locati F, Marchesi L, et al. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126 (8): 1103-4 (Pubitemid 20233193)
6. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a populationbased study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126 (1): 43-7 (Pubitemid 20040979)
7. Mittmann N, Chan B, Knowles S, et al. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 2006; 7 (6): 359-68 (Pubitemid 46998570)
8. Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123 (9): 1160-5 (Pubitemid 17119309)
9. Schneck J, Fagot JP, Sekula P, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients including the prospective EuroSCAR study. J Am Acad Dermatol 2008; 58 (1): 33-40 (Pubitemid 350298143)
10. Rzany B, Mockenhaupt M, Baur S, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol 1996; 49 (7): 769-73 (Pubitemid 26280728)
11. Dan M, Jedwab M, Peled M, et al. Allopurinol-induced toxic epidermal necrolysis. Int J Dermatol 1984; 23 (2): 142-4 (Pubitemid 14156617)
12. Halevy S, Ghislain PD, Mockenhaupt M, et al. Allopurinol is the most common Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58: 25-32 (Pubitemid 350298142)
13. Carroll OM, Bryan PA, Robinson RJ. Stevens-Johnson syndrome associated with long-acting sulfonamides. JAMA 1966; 195 (8): 691-3
14. Lyell A. Sulfonamides and Stevens-Johnson syndrome [letter]. Lancet 1982; 2 (8313): 1460
15. Aguiar D, Pazo R, Duran I, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004; 66 (3): 345-50 (Pubitemid 38258350)
16. Teraki Y, Shibuya M, Izaki S. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite difference in cutaneous presentations. Clin Exp Dermatol 2009; 35 (7): 723-8
17. Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm 2010; 67 (3): 206-13
18. Mockenhaupt M, Kelly JP, Kaufman D, et al. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal anti-inflammatory drugs: as multinational perspective. J Rheumatol 2003; 30 (10): 2234-40 (Pubitemid 37221857)
19. Vinod KS, Sethuraman G, Minz A. Stevens-Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol 2008; 74 (3): 238-40 (Pubitemid 351918878)
20. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128 (1): 35-44 (Pubitemid 350249390)
21. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens- Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333 (24): 1600-7
22. Rzany B, Mockenhaupt M, Stocker U, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany [letter]. Arch Dermatol 1993; 129 (8): 1059 (Pubitemid 23238616)
23. Saiag P, Caumes E, Chosidow O, et al. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992; 26 (4): 567-74
24. Carr A, Tindall B, Penny R, et al. Patterns of multiple-drug hypersensitivities in HIV-infected patients. AIDS 1993; 7 (11): 1532-3 (Pubitemid 23333849)
25. Rotunda A, Hirsch RJ, Scheinfeld N, et al. Severe cutaneous reactions associated with the use of human immundeficiency virus medications. Acta Derm Venereol 2003; 83 (1): 1-9 (Pubitemid 36223045)
26. Metry DW, Lahart CJ, Farmer KL, et al. Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine. J Am Acad Dermatol 2001; 44 (2 Suppl.): 354-7 (Pubitemid 32167665)
27. Warren KJ, Boxwell DE, Kim NY, et al. Nevirapine-associated Stevens- Johnson syndrome [letter]. Lancet 1998; 351 (9102): 567 (Pubitemid 28077565)
28. Bastuji-Garin S, Fouchard N, Bertochhi M, et al. SCORTEN: a severity-ofillness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149-53 (Pubitemid 30637181)
29. U.S. Food and Drug Administration. MedWatch: the FDA safety information and adverse event reporting program [online]. Available from URL: http:// www.fda.gov/Safety/MedWatch/default.htm [Accessed 2011 Oct 6]
30. Medicines and Healthcare Products Regulatory Agency. Yellow card [online]. Available from URL: http://yellowcard.mhra.gov.uk/ [Accessed 2011 Oct 6]